Articles By Rob Wright

41. How To Create An Innovative Culture In A Pharma Company 6/1/2012

    Endo Pharmaceuticals explains what it takes to boost an innovative culture for a pharma company. By Rob Wright

42. Connecting The FDA And Pharma / Biotech Industry 5/16/2012

    Even with more than 8,800 employees and an annual budget of around $3.2 billion, the FDA’s task of protecting the public health seems daunting, considering the complexity of products being developed by industry. By Rob Wright

43. Accelerating The Drug Approval Process 4/30/2012

    Allergan’s CEO, David Pyott, attributes some of the company’s success to securing a high proportion of  regulatory approvals around the globe due to  three things: Allergan’s business model, expertise through specialization, and attention to detail using the "flywheel effect." By Rob Wright

44. Pharmaceutical Serialization Is Doomed Unless We Implement A Big-Picture Approach 4/30/2012

    Pharmaceutical serialization could obtain a global standardization by learning from two different models which demonstrate a solution. By Rob Wright

45. Getting A Biotech Back On The Path Toward Commercialization 3/28/2012

    There has been much debate as to how much it costs to get a new drug from discovery to market — anywhere from Light and Waburton’s 2011 estimate of R&D costs being in the neighborhood of $59.4M to PhRMA’s mind-numbing figure of $1.32B. By Rob Wright

46. Building A Biotech In China 3/8/2012

    Pharmaceutical and biotech companies are looking to emerging markets as the next frontier for drug development, discovery, and perhaps, the next breakthrough. By Rob Wright, Life Science Leader magazine

47. An Unlikely Path To The Pharma C-Suite 2/9/2012

    Santosh Vetticaden had an unconventional approach to getting to the c-suite. With the ink barely dry on his Bachelor of Pharmacy degree, in 1980 he emigrated from India to Richmond, VA, to begin the pursuit of a Ph.D. in pharmacy and pharmaceutics. By Rob Wright, Life Science Leader magazine

48. Special Executive Roundtable: Single-Use Technology 7/6/2011

    The current trend toward green living and utilizing “earth-friendly goods” continues to rise. Green manufacturing has become so popular that there is even Green Manufacturing Expo. A recent report listed the top “greenest companies in biopharma.” All of the companies listed rank in the top 20 of pharmaceutical companies with regard to sales revenue and include such names as Merck, Novartis, and Pfizer. So where does single-use technology fit in the “Green” manufacturing process? Single-use: Is it just another term for disposable? By Rob Wright, Life Science Leader magazine

49. Trevena's Maxine Gowen: Next-Generation Leadership 6/9/2011

    In 2007, a group of scientists from Duke University began the process of pursuing VC funding to start a company. By Rob Wright, Life Science Leader magazine

50. Lessons Learned Help Pfizer Accelerate Biotherapeutic Development

    Six of the seven blockbuster biotherapeutics belonging to Big Pharma have roots to small biotechs (see Table 1). So too does Tim Charlebois, Ph.D., VP of technology and innovation strategy within Pfizer’s biotherapeutics pharmaceutical sciences (BTx Pharm Sci).